Continuing Medical Education (CME) session highlighted Liver Tumour Update.
Aster Medcity organized a special CME, the Frontiers in Liver Disease Conference with a focus on Liver Tumour Update on the 13th and 14th of August. The conference inaugurated at the Taj Gateway Hotel, Kochi. The Frontiers in Liver Disease Conference - ‘Liver Tumour Update kicked off on the 13th August at 8 pm with a Key Note address on GI Oncology in 2016 - “The Indian Scenario” by Dr. Mohandas Mallath, Senior Consultant, GI Oncology, Tata Medical Centre, Kolkata. Chairpersons for the opening session will be Dr. Philip Augustine, Managing Director, PVS Hospital, Kochi, Dr. Narayanan Kutty Warrier, Senior Consultant, Oncology, MIMS, Prof. K R V Kumar, Senior Consultant, Gastroenterology, Travancore Medcity.
Sessions on 14th August from 9:00 am till 3:30 pm held at Aster Medcity. The first session on Neuroendocrine Liver Metastasis specialists talking on the various aspects like Diagnosis and Staging, Role of a Surgeon, and Non-surgical options. The other sessions include updated from specialists on Hepatocellular Carcinoma focusing on Selection of Candidates for Liver Transplantation, Intra Arterial Radiation and the evolving role of Stereotactic Body Radiation Therapy (SBRT) in Liver Cancer. A session on Paediatric Liver Tumours discussed the role of a Multi-disciplinary team.
The post lunch session focused on Colorectal Liver Metastasis and Cholangiocarcinoma. The entire conference designed and structured in a way to give a complete update on Liver Tumours to the attending delegates.
Dr. Mathew Jacob, Lead Consultant, Hepato-pancreato-biliary (HPB) and Liver Transplantation, Aster Medcity and President of the Conference said, ‘With management of liver tumours changing at an incredible pace, we felt that it necessary to update our medical fraternity on the new frontiers in medicine for the treatment of liver tumours and hence we organized this conference. This CME designed to update practicing physicians and surgeons on the recent advances in management of common primary and metastatic liver tumours.’
Dr. Charles Panackel, Consultant, Hepatology & Liver Transplantation, Aster Medcity and Organising Secretary of the Conference said, ‘This conference eminent national facility from leading hospitals who deliberated on the practical and technical aspects in the field of liver tumours. This event, a great opportunity for doctors to keep up with the latest in liver tumour management and network with the most renowned names in the field.’
Dr. Harish Pillai, CEO Kerala, Aster DM Healthcare said, ‘With developments in medical science happening at a fast pace, these conferences are essential to keep doctors up to date with developments in their specialty. Aster Medcity always taken the lead in helping medical professionals keep up with the latest findings and innovations in medical science for the betterment of the patient.”
